奥翔药业
(603229)
| 流通市值：58.20亿 | | | 总市值：58.20亿 |
| 流通股本：8.30亿 | | | 总股本：8.30亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 951,092,010.08 | 1,000,056,464.13 | 1,149,730,467.72 | 1,222,571,907.8 |
| 交易性金融资产 | 3,771,514.56 | 3,813,960.97 | 3,874,718.69 | 3,935,980.4 |
| 应收票据及应收账款 | 253,057,698.8 | 357,097,847.28 | 316,746,777.8 | 142,033,885.49 |
| 应收账款 | 253,057,698.8 | 357,097,847.28 | 316,746,777.8 | 142,033,885.49 |
| 应收款项融资 | 4,392,789.82 | 2,405,305 | 4,560,422.07 | 4,380,081.71 |
| 预付款项 | 2,971,068.05 | 5,983,280.68 | 2,928,330.38 | 1,202,360.98 |
| 其他应收款合计 | 1,834,872.31 | 4,813,797.06 | 1,956,813.43 | 1,788,603.9 |
| 存货 | 373,704,810.92 | 369,876,896.08 | 367,833,357.2 | 398,300,261.45 |
| 其他流动资产 | 40,400,359.55 | 36,552,164.6 | 31,239,580.17 | 41,118,098.04 |
| 流动资产合计 | 1,631,225,124.09 | 1,780,599,715.8 | 1,878,870,467.46 | 1,815,331,179.77 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 500,000 | 500,000 | 500,000 | 500,000 |
| 其他非流动金融资产 | 70,101,481.65 | 100,558,681.76 | 72,412,803.91 | 72,060,765.18 |
| 固定资产 | 716,885,960.4 | 733,763,520.18 | 743,230,349.41 | 750,512,413.6 |
| 在建工程 | 305,247,003.3 | 300,687,879.39 | 294,044,692.56 | 285,276,849.26 |
| 使用权资产 | 358,381.56 | 358,381.56 | 603,063.13 | 847,744.7 |
| 无形资产 | 148,526,024.6 | 149,536,864.12 | 150,555,398.21 | 151,558,909.88 |
| 递延所得税资产 | 6,726,281.46 | 7,723,399.69 | 5,735,813.98 | 3,815,163.01 |
| 其他非流动资产 | 4,762,324.48 | 3,676,009.23 | 10,885,931.4 | 5,347,640.05 |
| 非流动资产合计 | 1,253,107,457.45 | 1,296,804,735.93 | 1,277,968,052.6 | 1,269,919,485.68 |
| 资产总计 | 2,884,332,581.54 | 3,077,404,451.73 | 3,156,838,520.06 | 3,085,250,665.45 |
| 流动负债: | | | | |
| 短期借款 | 270,091,646.68 | 316,214,775.07 | 440,668,599.87 | 410,606,296.16 |
| 交易性金融负债 | 785,823.01 | 2,560,026.59 | 3,525,374.18 | 489,448.22 |
| 应付票据及应付账款 | 215,218,500.94 | 244,045,275.26 | 225,013,709.87 | 270,095,922.34 |
| 其中：应付票据 | 91,832,952.82 | 108,420,474.39 | 100,759,504.57 | 83,711,760.8 |
| 应付账款 | 123,385,548.12 | 135,624,800.87 | 124,254,205.3 | 186,384,161.54 |
| 合同负债 | 843,273.78 | 712,351.58 | 1,099,019.9 | 963,939.05 |
| 应付职工薪酬 | 17,590,231.01 | 20,296,946.99 | 21,834,317.42 | 42,242,749.91 |
| 应交税费 | 3,763,205.87 | 15,868,097.37 | 16,306,102.78 | 7,848,961.16 |
| 其他应付款合计 | 1,883,251.63 | 1,199,972.98 | 884,239.41 | 1,879,630.63 |
| 一年内到期的非流动负债 | 23,055,406.26 | 1,065,406.26 | 1,559,195.14 | 1,794,630.05 |
| 其他流动负债 | 108,305.25 | 74,928.61 | 195,104.24 | 98,293.99 |
| 流动负债合计 | 533,339,644.43 | 602,037,780.71 | 711,085,662.81 | 736,019,871.51 |
| 非流动负债: | | | | |
| 长期借款 | 21,990,715.25 | 44,248,955.21 | 43,993,927.58 | 44,248,927.58 |
| 递延收益 | 40,911,316.26 | 42,182,117.31 | 34,572,651.69 | 35,623,652.73 |
| 非流动负债合计 | 62,902,031.51 | 86,431,072.52 | 78,566,579.27 | 79,872,580.31 |
| 负债合计 | 596,241,675.94 | 688,468,853.23 | 789,652,242.08 | 815,892,451.82 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 830,297,145 | 830,297,145 | 830,297,145 | 830,297,145 |
| 资本公积 | 440,225,349.82 | 440,225,349.82 | 440,225,349.82 | 440,225,349.82 |
| 减:库存股 | 50,010,777.47 | 50,010,777.47 | 50,010,777.47 | 50,010,777.47 |
| 其他综合收益 | -1,487,503.03 | -1,358,452.89 | -807,659.09 | -1,095,052.34 |
| 盈余公积 | 146,468,683.65 | 146,468,683.65 | 146,421,621.66 | 146,468,683.65 |
| 未分配利润 | 922,598,007.63 | 1,023,313,650.39 | 1,001,060,598.06 | 903,472,864.97 |
| 归属于母公司股东权益合计 | 2,288,090,905.6 | 2,388,935,598.5 | 2,367,186,277.98 | 2,269,358,213.63 |
| 股东权益合计 | 2,288,090,905.6 | 2,388,935,598.5 | 2,367,186,277.98 | 2,269,358,213.63 |
| 负债和股东权益合计 | 2,884,332,581.54 | 3,077,404,451.73 | 3,156,838,520.06 | 3,085,250,665.45 |
| 公告日期 | 2026-10-31 | 2026-08-29 | 2026-04-29 | 2026-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |